Rabies in Travelers: Deadly but Preventable

Rabies in Travelers: Deadly but Preventable

Recorded On: 10/02/2024

  • Register
    • 5 Year Healthcare Professionals (Medical Doctor, Physician) - Free!
    • 5 Year Healthcare Professionals (Nurse, Nurse Practitioner, Physician's Assistant, Pharmacist, Paramedic, Researchers) - Free!
    • 1 Year Healthcare Professionals (Medical Doctor, Physician) - Free!
    • LMIC Healthcare Professional Membership - Free!
    • Retiree Membership - Free!
    • 1 Year Healthcare Professionals (Nurse, Nurse Practitioner, Physician's Assistant, Pharmacist, Paramedic, Researchers) - Free!
    • Student Membership (Non-degreed/Non-licensed) - Free!
    • Staff - Free!

Title: Rabies in Travelers: Deadly but Preventable

Date: Wednesday, 2 October 2024

Time: 9.00 EDT UTC-04 (The webinar is approximately 90 minutes)

To check your time zone, go to the time and date website: Here

Registration Fee:

Complimentary

You must register to attend. If you are not a member and wish to attend, you can create a free profile here, but membership is always encouraged.

To ensure timely receipt of the Zoom link, kindly complete your registration for the webinar at least one hour before the scheduled start time. 


Summary:

Rabies, one of the world’s oldest diseases, is almost always fatal. At least 59,000 people die from rabies every year worldwide, with 95% of cases occurring in Africa and Asia. In lower- and middle-income countries, almost all of rabies cases are due to dog bites, with children under 15 years of age accounting for approximately half of cases. The global cost of rabies is estimated to be around US$ 8.6 billion per year, including deaths and health care costs, furthermore, affecting livelihoods and causing uncalculated psychological trauma. Though rabies in travelers is rare, exposures to animals during trips are more frequent. With proper measures, rabies in humans is entirely preventable, but post-exposure prophylaxis may not be available in destination countries, causing anxiety and trip disruptions. We’ll revisit ACIP’s latest recommendations and discuss pre- and post-exposure prophylaxis recommendations as well as common issues encountered by travelers.

Thank You To Our Sponsors

image

Webinar Faculty:

Planning Chairs:  

Dr. Yen Bui, Chair, PEC, ISTM 

Dr. Darvin Scott Smith, Co-Chair, PEC, ISTM

Dr. Lin Chen, Past President, ISTM


Moderator: 

Dr. Albie de Frey, MD

The Travel Doctor Corporate

Faculty of Health Sciences, University of the Witwatersrand

Johannesburg, South Africa


Speakers: 

Dr. Oula Itani, MD

Institute Pasteur, Medical Center, Paris, France


Dr. Agam Rao, MD, FIDSA

CAPT, US Public Health Service

Poxvirus and Rabies Branch

DHCPP / NCEZID/ Centers for Disease Control

Atlanta, Georgia, USA

 

Dr. Wasin Matsee, MD, MCTM, Dip

Thai Travel Clinic, Hospital for Tropical Diseases, Bangkok, Thailand

Travel Medicine Research Unit, Department of Clinical Tropical Medicine,

Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand 


Course Objectives: 

By the end of this webinar, the attendee should be able to:

- Review the rabies vaccine recommendations from ACIP and other national guidelines

- Discuss rabies prevention from a Travel Medicine perspective 

- Discuss rabies prevention and post-exposure prophylaxis from a destination country perspective  

Who Should Attend:

- Travel Health Practitioners – Doctors, Nurses, and Pharmacists

- Infectious Diseases and Tropical Diseases Practitioners

- Occupational Health Practitioners

- Military Medicine Practitioners

- Public Health Practitioners

- Family Medicine Practitioners 

- Any others who care for travelers, expats, and workers who might be exposed to rabies

Agam Rao

MD, FIDSA

U.S. Centers for Disease Control and Prevention’s Division of High Consequence Pathogens and Pathology

Agam Rao, MD is the chief medicalofficer for the Poxvirus and Rabies Branch of the U.S. Centers for DiseaseControl and Prevention (CDC). She is a rabies and poxvirus subject matterexpert and leads the branch’s clinical and vaccine work including overseeingthe clinical consultation services for management of these pathogens and thevaccine recommendations of the Advisory Committee on Immunization Practices.Dr. Rao began her public health career as a CDC Epidemic Intelligence ServiceOfficer in 2009. She is a Captain in the Commissioned Corps of the U.S. PublicHealth Service and a fellow of the Infectious Disease Society of America.

Oula Itani

MD

Dr Oula Itani is an Infectious Diseases physician at the Medical Center of the Institut Pasteur in Paris, France, where she started working after training in travel medicine and tropical diseases. Aside from her clinical work in the travel clinic for pre-travel counselling and post-travel management, she also participates in France’s largest rabies center, where roughly 1400 patients are seen yearly for post-exposure prophylaxis.  

Wasin Matsee

MD, MCTM, Dip

Dr. Wasin Matsee, a travel medicine specialist, serves as a Assistant Professor at the Travel Medicine Research Unit, Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University and attending physician at the Thai Travel Clinic, Hospital for Tropical Diseases, Bangkok, Thailand. My research interests are involved with travel medicine, travel-related diseases, vaccines and clinical tropical medicine.

 

 

 

 

 

 

Albert de Frey (Moderator)

MD

Obtained medical degree from the University of Pretoria in 1983 followed by Diplomas in Primary Emergency Care and Anesthesiology from the South African College of Medicine and a Diploma in Travel Medicine from the University of Glasgow and Certificate in Travel Health from the International Society of Travel Medicine. Fellow of the Faculty of Travel Medicine of the Royal College of Physicians and Surgeons, Glasgow, Scotland and the Faculty of Travel Medicine of the Australasian College of Tropical Medicine, Australia.

 Senior Honorary Lecturer in the School of Public Health, Faculty of Health Sciences at the University of the Witwatersrand and instrumental in the development of WITS’s Travel Medicine Course developed in conjunction with James Cook University, Townsville, Australia.

 Member of the WHO Expert Roster on Travel Health, Geneva, Switzerland, Site Director GeoSentinel, Johannesburg, South Africa, Founding member of Travel Doctor Corporate, Director of the Travel Doctor in South Africa, Medical Director of International Health Management Consultants, Geneva, Switzerland

 Currently involved in providing comprehensive travel health risk management to several multi- national companies, taking care of approximately 5 500 corporate travelers and national employees globally.

 Editorial Board Appointments (Past and present):

Associate Editor - The Southern African Journal of Epidemiology & Infection

Elected Member of Editorial Board of Travel Medicine and Infectious Disease, Elsevier

Review Committee Member - International Travel and Health (ITH), WHO

Editorial Board Member - Tropical Medicine and Infectious Disease

 South African Society of Travel Medicine: Founding & Executive Committee Member

International Society of Travel Medicine: Travel for Work Council Member

Lived and worked in South Africa, Malawi and the UK and travels extensively to service the needs of corporate clients and as invited speaker at national and international conferences.

 Conducted Health Risk and Infrastructure audits in all of Sub-Saharan Africa with the exception of The Gambia, Togo, Benin, Niger, Somalia and Lesotho, in Afghanistan and parts of the Middle East and South-East Asia over a period spanning 25 years.

 Considers every malaria death in a non-immune traveler a personal failure.

 

Key:

Complete
Failed
Available
Locked
Rabies in Travelers: Deadly but Preventable
Open to view video.  |  90 minutes
Open to view video.  |  90 minutes Rabies, one of the world’s oldest diseases, is almost always fatal. At least 59 000 people die from rabies every year worldwide, with 95% of cases occurring in Africa and Asia. In lower and middle income countries, almost all of rabies cases are due to dog bites, with children under 15 years of age accounting for approximately half of cases. The global cost of rabies is estimated to be around US$ 8.6 billion per year, including deaths and health care costs, furthermore, affecting livelihoods and causing uncalculated psychological trauma. Though rabies in travellers is rare, exposures to animals during trips are more frequent. With proper measures, rabies in humans is entirely preventable, but postexposure prophylaxis may not be available in destination countries, causing anxiety and trip disruptions. We’ll revisit ACIP’s latest recommendations and discuss pre- and post-exposure prophylaxis recommendations as well as common issues encountered by travelers.
Oula Itani - 2 October 2024 - Experience of a French center
Recorded 10/02/2024  |  27 minutes
Recorded 10/02/2024  |  27 minutes Oula Itani - 2 October 2024 - Experience of a French center
Agam Rao - 2 October 2024 - Preexposure Prophylaxis to Prevent Human
Recorded 10/02/2024  |  28 minutes
Recorded 10/02/2024  |  28 minutes Agam Rago - 2 October 2024 - Preexposure Prophylaxis to Prevent Human
Wasin Matsee - 2 October 2024 - Rabies in Travelers: Deadly but Preventable
Recorded 10/02/2024  |  30 minutes
Recorded 10/02/2024  |  30 minutes Wasin Matsee - 2 October 2024 - Rabies in Travelers: Deadly but Preventable
Survey
15 Questions
CPD Certificate
1.50 Continuing Professional Development credits  |  Certificate available
1.50 Continuing Professional Development credits  |  Certificate available